新闻
10 小时之前
Inventiva and Hepalys Pharma, Inc.  announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea
引进/卖出临床3期快速通道
10 小时之前
argenx Announces VYVGART (efgartigimod alfa) Authorized for Sale by Health Canada  for Generalized Myasthenia Gravis
临床结果上市批准免疫疗法
11 小时之前
引进/卖出临床结果
11 小时之前
Alvotech Provides U.S. Regulatory Update on AVT02, a High-Concentration Interchangeable Biosimilar Candidate to Humira® (adalimumab)
上市批准生物类似药申请上市加速审批
11 小时之前
Addex mGlu2 NAM Cognition Program Receives €4 Million Grant
临床2期
11 小时之前
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
临床研究基因疗法
11 小时之前
Hepion Pharmaceuticals Discovers Novel Rencofilstat Action in Liver Cancer
孤儿药快速通道
12 小时之前
细胞疗法基因疗法
2023-09-20
POINT Biopharma and Athebio Announce Partnership to Develop Designed Ankyrin Repeat Protein Targeted Radioligands
临床3期引进/卖出临床1期
2023-09-20
PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target
合格传染病产品